ACE Hemoglobin A1c (HbA1c) Reagent
Assay, Glycosylated Hemoglobin. 510(k) K170623, from Alfa Wassermann Diagnostic Technologies, LLC (West Caldwell, NJ). Product code LCP, class 2.
As of Nov 21, 2026, K170623 is an FDA 510(k) held by Alfa Wassermann Diagnostic Technologies, LLC, substantially equivalent on Feb 27, 2018 after 363 days, with no recalls tied to it in FDA's recall database.
- Review time: 363 days
- Recalls: 0
ACE Hemoglobin A1c (HbA1c) Reagent is intended for the quantitative determination of percent hemoglobin A1c in venous whole blood collected in K2-EDTA tubes using the ACE Alera® and ACE Axcel® Clinical Chemistry Systems. This test is intended for use in clinical laboratories and physician office laboratories to monitor long term blood glucose control in individuals with diabetes mellitus.
- Dca 2000 System for Hemoglobin A1CK951361 · Heraeus Kulzer, Inc. · May 5, 1995
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 1, 2017
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files